There were 1,598 press releases posted in the last 24 hours and 442,737 in the last 365 days.

The global smart syringe market was valued at $5,737 million in 2017, and is estimated to garner $13,792 million by 2025

Smart Syringe Market by Product Type (Auto Disable, Active Safety, and Passive Safety), Application (Drug Delivery, Vaccination, and Blood Specimen Collection), Age Group (Pediatric and Adult), and End User, (Hospitals and HMOs, Diabetic Patients, Family Practices, and Psychiatrics): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

New York, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Smart Syringe Market by Product Type, Application, Age Group, and End User,: Global Opportunity Analysis and Industry Forecast, 2018 - 2025" - https://www.reportlinker.com/p05663896/?utm_source=GNW

Smart Syringe Market Overview :

The global smart syringe market was valued at $5,737 million in 2017, and is estimated to garner $13,792 million by 2025, registering a CAGR of 10.3% during the forecast period. Smart syringes are designed with features to offer protection from needle stick injuries, blood-borne diseases such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), and life-threatening infections. They cater to several applications that include vaccination, drug delivery, and blood specimen collection. Smart syringes are of various types, which include auto disable (AD) syringes, passive safety syringes, and active safety syringes are used depending on the nature of application. Active safety syringes are the most common type of smart syringes used across all healthcare sectors, whereas, auto disable (AD) syringes are the most popular syringes used for vaccination purpose.

The industry is driven by increase in needle stick injuries, high prevalence of blood-borne transmission such as hepatitis B, C, HIV through improper injection practices, growth in adoption of safety syringes, and surge in technological advancements. In addition, the WHO mandate to switch to smart syringes to ensure safe injection practices is a major factor that boosts the growth of the market. However, high cost associated with smart syringes, especially passive safety syringes, low awareness in developing economies, and alternative drug delivery methods are expected to impede the market growth. The global smart syringes market volume is projected to reach 15.8 billion units by 2020 and is anticipated to grow at a CAGR of 8.2 during the forecast period.

The global smart syringe market is segmented based on product type, application, age group, end user, and region. Based on product type, the market is segmented into auto disable (AD) syringes, active safety syringes, and passive safety syringes. Based on application, the market is classified into drug delivery, vaccination, and blood specimen collection. Based on age group, the market is bifurcated into pediatric and adult. Based on end user, the market is categorized into hospitals and HMOs, diabetic patients, family practices, psychiatrics, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Market Benefits for Smart Syringe Market :

This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities.

Market estimations are based on a comprehensive analysis of the key developments in the industry.

The global market is comprehensively analyzed with respect to product type, application, age group, end user, and region.

In-depth analysis based on region helps understand the regional market to assist in strategic business planning.

The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Smart Syringe Key Market Segments :

By Product Type
Auto disable syringes

Active safety syringes

Passive safety syringes

By Application
Drug delivery

Vaccination

Blood specimen collection

By Age Group
Pediatric

Adult

By End User
Hospitals and HMOs

Diabetic patients

Family practices (Physicians)

Psychiatrics

Others

By Region
North America

U.S.

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia-Pacific

Japan

China

India

Rest of Asia-Pacific

LAMEA

Brazil

Saudi Arabia

South Africa

Rest of LAMEA

KEY PLAYERS PROFILED
Welltok, Inc.

Intel Corporation

Nvidia Corporation

Google Inc.

IBM Corporation

Microsoft Corporation

General Vision, Inc.

Enlitic, Inc.

BioXcel Corporation

Berg Health

The other players of the smart syringe market include (companies not profiled in the report):
L.O.M. Medical International

Techcon, Tecan Trading AG

Meissner Filtration Products, Inc.

ARxIUM

Parker Hannifin Corporation
Read the full report: https://www.reportlinker.com/p05663896/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.